| Literature DB >> 25814709 |
Arvind Krishnamurthy1, Vijayalakshmi Ramshankar2, Thangaraj Viveka Soundara2, Urmila Majhi3.
Abstract
Verrucous carcinoma (VC) is a clinicopathologic entity which is defined as a locally aggressive, clinically exophytic, slow-growing, well-differentiated, squamous cell carcinoma with negligible metastatic potential. The cutaneous form of VC is typically known to arise from the palmoplantar and the genitocrural areas. Involvement of the scalp is extremely rare. Multiple synchronous involvement of the scalp by VC along with associated generalized verruca vulgaris has possibly never been reported before. We present this unique report of VC in a 38-year-old male patient with emphasis on its atypical clinical presentation and the resultant challenges in management. Interestingly, the tumor cells of our patient were confirmed to be positive for human papillomavirus infection by polymerase chain reaction and by p16 immunohistochemistry.Entities:
Keywords: Human papillomavirus; scalp tumors; verrucous carcinoma
Year: 2015 PMID: 25814709 PMCID: PMC4372913 DOI: 10.4103/0019-5154.152524
Source DB: PubMed Journal: Indian J Dermatol ISSN: 0019-5154 Impact factor: 1.494
Figure 1(a and b) Clinical picture at presentation
Figure 2Reconstructed image of the computed tomography (CT) scan of the head and neck showing the cutaneous verrucous carcinomas in the scalp alongside the warts.
Figure 3(a and b) Tumor composed of marked verrucous hyperplasia of squamous epithelium with reduplication, down growths, pushing borders, and mild nuclear atypia; the clinicopathological picture was suggestive of a verrucous carcinoma (hematoxylin and eosin (H and E), ×20). (c) Verrucous carcinoma showing mild focal immunopositivity for p16 (H and E, ×10). (d) Figure showing the polymerase chain reaction (PCR) amplification of the sample deoxyribonucleic acid (DNA) showing human papillomavirus (HPV) infection using consensus primer GP5+ and GP6+ showing lane 1-7 in the PCR ladder; Lane 3 - positive control (HeLa cells), lane 4 - tumor sample; and lane 6 - negative control
Figure 4Clinical photograph of the patient 1 month post-surgery and radiotherapy